Jyothy Labs Q4 profit rises 895.7% to Rs107.4 crore
Jyothy Labs says the net sales of Rs465.6 crore for the fourth quarter was up 3.7% as against Rs448.7 crore for the corresponding quarter last year18-05-2017
Jyothy Labs Q4 profit rises 895.7% to Rs107.4 crore
Jyothy Labs says the net sales of Rs465.6 crore for the fourth quarter was up 3.7% as against Rs448.7 crore for the corresponding quarter last yearAnalyst Meet Presentation
Copy of presentation to be made at the Analyst Meet on Company's performance for the quarter and financial year ended March 31, 2017 and the way forward scheduled to be held at 3.45 p.m. today i.e. May 18, 2017.Board recommends Final Dividend
Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2017, inter alia, have recommended Final Dividend of Rs. 6/- (Rupees Six Only) per equity share of Re. 1/- each for the financial year ended March 31, 2017, which if approved by the shareholders at the ensuing Annual General Meeting, will be paid / dispatched on or before July 15, 2017.AGM On July 11, 2017 At 11.00 A.M.
26th Annual General Meeting of the Company to be held on Tuesday, July 11, 2017 at 11.00 a.mFixed Record Date For The Purpose Of Payment Of Dividend And 26Th Annual General Meeting Of The Company
The Board has fixed the Record Date as Wednesday, July 5, 2017 to Tuesday, July 11, 2017 (both days inclusive) for the purpose of payment of dividend and 26th Annual General Meeting of the CompanyBoard to consider Dividend
The Board at its meeting held on May 18, 2017 recommended Final Dividend of Rs.6/- (Rupees Six Only) per equity share of Re.1/- each for the financial year ended March 31, 2017, which if approved by the shareholders at the ensuing Annual General Meeting, will be paid/ dispatched on or before July 15, 2017Outcome Of Board Meeting
Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2017. A copy of the said results accompanied with the Audit Report issued by M/s. S R B C & Co. LLP, Statutory Auditors of the Company is attached herewith.Intimation Of Schedule Of Analyst Meet/ Conference Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst Meet/ Conference to be held on May 18, 2017Board to consider Dividend
Jyothy Laboratories Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on May 18, 2017 inter-alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2017 and to consider and recommend dividend, if any, on the Equity Shares of the Company for the financial year 2016-17.